In the third study, patients taking Reyataz or lopinavir, in combination with ritonavir, had similar falls in viral load after 24 and 48 weeks, having fallen by around 99% after 48 weeks.
Viiruskoormus vähenes 48 - nädalase ravi järel ligikaudu 99% võrra.